Majors Cary L 4

4 · STERIS plc · Filed May 22, 2025

Form 4

Period: 2025-05-20

SVP and President, Healthcare

Transactions

Sale
Ordinary Shares
2025-05-20$250.71/sh−4,581$1,148,503→ 11,372 total
Sale
Ordinary Shares
2025-05-20$249.73/sh−8,247$2,059,523→ 15,953 total
Exercise/Conversion
Ordinary Shares
2025-05-20$147.05/sh+12,828$1,886,357→ 24,200 total
Exercise/Conversion
Employee Stock Option (right to buy)
2025-05-20−12,828→ 0 total
Exercise: $147.05Exp: 2029-05-31→ Ordinary Shares (12,828 underlying)

Holdings

Footnotes (5)

[F1]As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027.
[F2]Price reflects a weighted average sale price for multiple transactions ranging from $249.46 to $250.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F3]Price reflects a weighted average sale price for multiple transactions ranging from $250.50 to $251.04 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F4]Units representing 67 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 20, 2025.
[F5]This option is fully vested.

Documents

1 file